Altered leptin signaling in utero may predispose the fetus to leptin resistance and possibly be the link to the high rates of fetal overgrowth, childhood obesity, and the risk of developing asthma later in childhood (Yura et al., 2005; Stefaniak et al., 2019; Castro-Rodriguez et al., 2020). The gene discussed is LEP; the disease is asthma.